[1]
|
Cragg, G.M., Newman, D.J., Snader, K.M. (1997) Natural products in drug discovery and development. J. Nat. Prod. 60, 52-60. doi:10.1021/np9604893
|
[2]
|
Kopka, M.L., Yoon, C., Goodsell, D., Pjura, P., Dickerson, R.E. (1985) The molecular origin of DNA-drug specificity in netropsin and distamycin. Proc. Natl. Acad. Sci. U.S.A. 82, 1376-1380.
doi:10.1073/pnas.82.5.1376
|
[3]
|
Tse, W.C., Boger, D.L. (2004) Sequence-selective DNA recognition: natural products and nature's lessons. Chem. Biol. 11, 1607-1617. doi:10.1016/j.chembiol.2003.08.012
|
[4]
|
Wang, A.H., Ughetto, G., Quigley, G.J., Rich, A. (1987) Interactions between an anthracycline antibiotic and DNA: molecular structure of daunomycin complexed to d(CpGpTpApCpG) at 1.2-? resolution. Biochemistry 26, 1152-1163. doi:10.1021/bi00378a025
|
[5]
|
Umezawa, H., Maeda, K., Takeuchi, T., Okami, Y. (1966) New antibiotics, bleomycin A and B. J. Antibiot. (Tokyo) 19, 200-209.
|
[6]
|
Blum, R.H., Carter, S.K., Agre, K. (1973) A clinical review of bleomycin--a new antineoplastic agent. Cancer 31, 903-914. doi:10.1002/1097-0142(197304)31:4<903::AID-CNCR2820310422>3.0.CO;2-N
|
[7]
|
Umezawa, H. (1974) Chemistry and mechanism of action of bleomycin. Fed. Proc. 33, 2296-2302.
|
[8]
|
Stubbe, J.A., Kozarich, J.W., Wu, W., Vanderwall, D.E. (1996) Bleomycins: A structural model for specificity, binding, and double strand cleavage. Acc. Chem. Res. 29, 322-330. doi:10.1021/ar9501333
|
[9]
|
Boger, D.L., Ramsey, T.M., Cai, H., Hoehn, S.T., Stubbe, J.A. (1998) A systematic evaluation of the bleomycin A(2) L-threonine side chain: Its role in preorganization of a compact conformation implicated in sequence-selective DNA cleavage. J. Am. Chem. Soc. 120, 9139-9148. doi:10.1021/ja9816638
|
[10]
|
Tanaka, W. (1977) Development of new bleomycins with potential clinical utility. Jpn. J. Antibiot. 30, Suppl. 41-8.
|
[11]
|
Boger, D.L., Cai, H. (1999) Bleomycin: Synthetic and mechanistic studies. Angew. Chem. - Intl. Ed. 38, 448-476.
doi:10.1002/(SICI)1521-3773(19990215)38:4<448::AID-ANIE448>3.0.CO;2-W
|
[12]
|
Hecht, S.M. (2000) Bleomycin: new perspectives on the mechanism of action. J. Nat. Prod. 63, 158-168.
doi:10.1021/np990549f
|
[13]
|
Stubbe, J.A., Kozarich, J.W. (1987) Mechanisms of bleomycin-induced DNA-degradation. Chem. Rev. 87, 1107-1136. doi:10.1021/cr00081a011
|
[14]
|
Burger, R.M., Peisach, J., Horwitz, S.B. (1982) Effects of O2 on the reactions of activated bleomycin. J. Biol. Chem. 257, 3372-3375.
|
[15]
|
Breen, A.P., Murphy, J.A. (1995) Reactions of oxyl radicals with DNA. Free Rad. Biol. Med. 18, 1033-1077.
doi:10.1016/0891-5849(94)00209-3
|
[16]
|
Wu, W., et al (2002) Solution structure of the hydroperoxide of Co(III) phleomycin complexed with d(CCAGGCCTGG)2: evidence for binding by partial intercalation. Nucleic Acids Res. 30, 4881-4891.
doi:10.1093/nar/gkf608
|
[17]
|
Zhao, C., et al (2002) Structures of HO(2)-Co(III)bleomycin A(2) bound to d(GAGCTC)(2) and d(GGAAGCTTCC)(2): structure-reactivity relationships of Co and Fe bleomycins. J. Inorg. Biochem. 91 259-268. doi:10.1016/S0162-0134(02)00420-8
|
[18]
|
Papakyriakou, A., Mouzopoulou, B., Katsaros, N. (2003) The solution structure of the Ga(III)-bleomycin A2 complex resolved by NMR and molecular modeling; interaction with d(CCAGGCCTGG). J. Biol. Inorg. Chem. 8, 549-459.
|
[19]
|
Lehmann, T.E., Ming, L.J., Rosen, M.E., Que, Jr, L. (1997) NMR studies of the paramagnetic complex Fe(II)-bleomycin. Biochemistry 36, 2807-2816.
doi:10.1021/bi962748t
|
[20]
|
Lin, P.S., Kwock, L., Hefter, K., Misslbeck, G. (1983) Effects of iron, copper, cobalt, and their chelators on the cytotoxicity of bleomycin. Cancer Res. 43, 1049-1053.
|
[21]
|
Rao, E.A., Saryan, L.A., Antholine, W.E., Petering, D.H. (1980) Cytotoxic and antitumor properties of bleomycin and several of its metal complexes. J. Med. Chem. 23, 1310-1318. doi:10.1021/jm00186a006
|
[22]
|
Decker, A., Chow, M.S., Kemsley, J.N., Lehnert, N., Solomon, E.I. (2006) Direct hydrogen-atom abstraction by activated bleomycin: an experimental and computational study. J. Am. Chem. Soc. 128, 4719-4733.
doi:10.1021/ja057378n
|
[23]
|
Kumar, D., Hirao, H., Shaik, S., Kozlowski, P.M. (2006) Proton-shuffle mechanism of O-O activation for formation of a high-valent oxo-iron species of bleomycin. J. Am. Chem. Soc. 128, 16148-16158.
doi:10.1021/ja064611o
|
[24]
|
Chow, M.S:, Liu, L.V., Solomon, E.I. (2008) Further insights into the mechanism of the reaction of activated bleomycin with DNA. Proc. Natl. Acad. Sci. U.S.A. 105, 13241-132415. doi:10.1073/pnas.0806378105
|
[25]
|
Karawajczyk, A., Buda, F. (2005) The metal bonding domain of the antitumor drug Fe(II)-bleomycin: A DFT investigation. J. Biol. Inorg. Chem. 10, 33-40.
doi:10.1007/s00775-004-0610-8
|
[26]
|
Krieger, E., Darden, T., Nabuurs, S.B., Finkelstein, A., Vriend, G. (2004) Making optimal use of empirical energy functions: Force-field parameterization in crystal space. Proteins - Struct. Func. Bioinf. 57, 678-683.
|
[27]
|
Zhao, C., et al (2002) Structures of HO2-Co(III)bleomycin A2 bound to d(GAGCTC)2 and d(GGAAGCTTCC)2: structure-reactivity relationships of Co and Fe bleomycins. J. Inorg. Biochem. 91, 259-268.
doi:10.1016/S0162-0134(02)00420-8
|
[28]
|
Duan, Y., et al (2003) A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. J. Comp. Chem. 24, 1999-2012. doi:10.1002/jcc.10349
|
[29]
|
Essmann, U., Perera, L., Berkowitz, M.L., Darden, T., Lee, H., Pedersen, L.G. (1995) A smooth particle mesh ewald method. J. Chem. Phys. 103, 8577-8593.
doi:10.1063/1.470117
|
[30]
|
WL Jorgensen, W.L. (1981) Quantum And Statistical Mechanical Studies Of Liquids .10. Transferable Intermolecular Potential Functions For Water, Alcohols, And Ethers - Application To Liquid Water. J. Am. Chem. Soc. 103, 335-340. doi:10.1021/ja00392a016
|